This is the authors' abstract. We don't add key points for this paper.
The surface of synthetic calcium hydroxyapatite (HA, Ca10(PO4)6(OH)2) was modified through combining freeze-drying, solvent replacement and surface modification methods in an effort to obtain the deaggregative n-HA crystallites. Three surface modification agents: Polyethylene glycol (PEG, Mw: 6000), poly(propyl oxide)-poly (ethyl oxide)-co-poly(propyl oxide)(Pluronic F-127, Mw: 12,000) and poly(d, l-lactide)-co-poly (ethylene glycol) (PELA, Mw: 20,000)were selected. The dispersion of the modified n-HA was characterized by sedimentation time in distilled water, acetone and dimethyl formamide (DMF). The results indicate that the three surface modification agents influence the dispersion of n-HA crystallites in various solvent based on different mechanisms. Transmission electron microscopy (TEM) observation shows that the dried and acetone-replacement powders are composed of needle-like HA crystallites isolated individually. The chosen solvents have a profound effect on the sedimentation time. In distilled water, the dispersion of as-synthesized n-HA crystallites is increased greater by F127 than by PEG. After freeze-drying, the two n-HA particles show homogeneous dispersion in acetone. The colloid stability of freeze-dried HA/PEG, solution-replaced HA/F127 and solution-replaced HA/PELA in DMF were improved significantly. The suspensions remained stable after 30 days with only a blue transparent sol being observed.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2005) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: